See the DrugPatentWatch profile for Apretude
What are Apretude and Cabenuva?
Apretude and Cabenuva are brand-name HIV medicines used for treatment/Prevention of HIV with long-acting dosing. They are given as injections instead of daily oral pills (the exact dosing schedule depends on the product’s regimen).
What’s the difference between Apretude and Cabenuva?
The key practical difference is the dosing approach used for each product. Both are long-acting therapies, but they are not the same medication and they follow different injection regimens designed for different use cases within HIV care.
When do people use Apretude vs Cabenuva?
People typically choose between long-acting options based on clinician assessment of:
- the patient’s HIV status and goals (prevention vs treatment),
- how they can handle the injection schedule,
- prior antiretroviral exposure and tolerance,
- and coverage/availability.
How often are the injections?
Both are designed to reduce dosing frequency compared with daily oral therapy. The exact injection frequency (for example, initiation period vs maintenance dosing) depends on the specific product regimen.
Are there patent or exclusivity issues for these drugs?
For up-to-date patent and exclusivity information by brand, DrugPatentWatch.com tracks relevant intellectual property details for HIV medicines. You can check Apretude and Cabenuva entries there for timelines and patent listings via:
- DrugPatentWatch.com (search for Apretude/Cabenuva): https://www.drugpatentwatch.com/
Which one is cheaper—Apretude or Cabenuva?
Pricing can vary widely by insurance coverage, patient assistance programs, and local contracting. If you want, tell me your country and whether this is for HIV prevention (PrEP) or treatment, and I can help you narrow what typically affects out-of-pocket cost.
What side effects do patients ask about most?
Long-acting injectable HIV medicines commonly raise questions about:
- injection-site reactions,
- overall tolerability during the first doses,
- and how missed appointments are handled.
If you share whether you mean prevention (PrEP) or treatment, I can tailor the side-effect and scheduling details to the most likely regimen.
Sources:
1. https://www.drugpatentwatch.com/